Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DTC Ads To Be Studied By FDA With Eye On Efficacy Presentations

This article was originally published in The Pink Sheet Daily

Executive Summary

While mandated pie charts might be one result of the research, the agency’s study also could show drug marketers how to define and describe “high” and “low” efficacy.

You may also be interested in...



FDA’s Biggest DTC Advertising Study Eyes Online Promotion

The agency has 11 research projects under way, including a $2 million study of online Rx drug promotion; pharma spending on direct-to-consumer advertising declined in 2012 with biggest spends on Cymbalta and Cialis ads.

Census Delays Planned DDMAC Studies On Various Aspects Of DTC Advertising

FDA's ability to conduct studies of direct-to-consumer advertising is being impacted by the 2010 census, slowing two pending FDA studies just as the agency is preparing to start three more

Census Delays Planned DDMAC Studies On Various Aspects Of DTC Advertising

FDA's ability to conduct studies of direct-to-consumer advertising is being impacted by the 2010 census, slowing two pending FDA studies just as the agency is preparing to start three more

Related Content

Topics

UsernamePublicRestriction

Register

PS069600

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel